期刊文献+

无创双水平气道正压通气辅助治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭43例临床分析 被引量:6

Clinical analysis of noninvasive bi-level positive airway pressure in COPD complicated with type Ⅱ respiratory failure
原文传递
导出
摘要 目的观察无创双水平气道正压通气(BiPAP)辅助治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭的疗效。方法将我院RICU的84例COPD合并Ⅱ型呼吸衰竭患者,随机分为无创通气组和常规治疗组。两组均予常规药物治疗。无创组辅以BiPAP无创通气,常规组予鼻导管吸氧,观察治疗2 h前后动脉血气的变化及无创通气对患者插管率的影响。结果相对于常规治疗组,BiPAP无创通气2 h可有效纠正呼吸性酸中毒,降低PCO2,提高PO2,降低插管率(P均<0.05)。结论 BiPAP无创通气可缓解COPD合并Ⅱ型呼吸衰竭患者呼吸困难,改善血气,降低气管插管率。 Objective To observe the therapeutic effects of noninvasive bi -level positive airway pressure (BiPAP) ventilation on chronic obstructive pulmonary disease(COPD) complicated with type Ⅱ respiratory failure patients. Methods Eighty - four cases of COPD complicated with type Ⅱ respiratory failure in our hospital RICU were randomly divided into the noninvasive group and the conventional group. Besides routine drug therapy, 43 cases in the noninvasive group were administered with BiPAP ventilation, other 41 cases in the conventional group were administered with oxygen inhalation through nasal catheter. The changes of arterial blood gas, reintubation rate were observed in the two groups. Results Compared with the conventional group, the noninvasive group had better blood gas improvement and lower reintubation rate after 2 hours of noninvasive ventilation (P 〈 0. 05). Conclusion The noninvasive BiPAP ventilation can relieve the syndrome of dyspnea, improve blood gas and lower reintubation rate for COPD complicated with type Ⅱ respiratory failure cases.
出处 《临床医学》 CAS 2014年第7期7-9,共3页 Clinical Medicine
关键词 慢性阻塞性肺疾病 呼吸衰竭 无创通气 Chronic obstructive pulmonary disease (COPD) Respiratory failure Noninvasive bi -level positive airway pressure (BiPAP)
  • 相关文献

参考文献4

二级参考文献37

共引文献2628

同被引文献44

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2061
  • 2蔡柏蔷.呼吸内科学[M].北京:中国协和医科大学出版社,2000.812.
  • 3朱蕾.机械通气[M].3版.上海:上海科学技术出版社,2012:55-114.
  • 4张国初.高压氧早期治疗弥漫性轴索损伤的疗效观察.中华医学会第二十二次全国高压氧医学学术论文汇编,2013:192.
  • 5GOLD Executive Committee.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease(Revised2011)[J/OL].[2012-11-16].http:www.goldcopd.com.
  • 6Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):753-760.
  • 7Tan WC,Ng TP.COPD in Asia;where East meets West[J].Chest,2008,133(2):517-527.
  • 8Piquilloud L,Vignaux L.Bialais E,et al.Neurally adjusted ventilatory assist improves patient-ventilator interaction[J].Intensive Care Med,2011,37(2):263-271.
  • 9Singh S,Loke YK.Furberg CD.Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease:a systematic review and meta-analysis[J].JAMA,2008,300(12):1439-1450.
  • 10Tashkin DP.Long-acting anticholinergic use in chronic obstructive pulmonary disease:efficacy and safety[J].Curr Opin Pulm Med,2010,16(2):97-105.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部